Earnings Call · Q1 FY2022·2022-05-04

Q1 22EPS +63.84%·Rev n/aQ4 21EPS -36.83%·Rev n/aQ3 21EPS -4.47%·Rev n/aQ2 21EPS +14.89%·Rev n/a⚠ consensus missing

UNITED THERAPEUTICS Corp UTHR

Dewey Steadman — Head of Investor Relations

Martine Rothblatt — Chairperson and Chief Executive Officer

Michael Benkowitz — President and Chief Operating Officer

+3.7%1d on move date+0.7% vs SPY3d+2.5%5d−0.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more UTHR calls or request research access.

More UTHR calls Browse calls Request research access